These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22884661)

  • 41. Toll-Like Receptor 4 Regulates Rabies Virus-Induced Humoral Immunity through Recruitment of Conventional Type 2 Dendritic Cells to Lymph Organs.
    Chen C; Zhang C; Li H; Wang Z; Yuan Y; Zhou M; Fu ZF; Zhao L
    J Virol; 2021 Nov; 95(24):e0082921. PubMed ID: 34613801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A heterologous prime-boost Ebola virus vaccine regimen induces durable neutralizing antibody response and prevents Ebola virus-like particle entry in mice.
    Chen T; Li D; Song Y; Yang X; Liu Q; Jin X; Zhou D; Huang Z
    Antiviral Res; 2017 Sep; 145():54-59. PubMed ID: 28733113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice.
    Sunay MME; Martins KAO; Steffens JT; Gregory M; Vantongeren SA; Van Hoeven N; Garnes PG; Bavari S
    Vaccine; 2019 Jun; 37(29):3902-3910. PubMed ID: 31174937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.
    Vu H; Shulenin S; Grolla A; Audet J; He S; Kobinger G; Unfer RC; Warfield KL; Aman MJ; Holtsberg FW
    Antiviral Res; 2016 Feb; 126():55-61. PubMed ID: 26681387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Chimeric Sudan Virus-Like Particle Vaccine Candidate Produced by a Recombinant Baculovirus System Induces Specific Immune Responses in Mice and Horses.
    Wu F; Zhang S; Zhang Y; Mo R; Yan F; Wang H; Wong G; Chi H; Wang T; Feng N; Gao Y; Xia X; Zhao Y; Yang S
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31947873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens.
    da Fontoura Budaszewski R; Hudacek A; Sawatsky B; Krämer B; Yin X; Schnell MJ; von Messling V
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs.
    Locher S; Schweneker M; Hausmann J; Zimmer G
    J Gen Virol; 2018 Jul; 99(7):866-879. PubMed ID: 29869979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective Efficacy and Long-Term Immunogenicity in Cynomolgus Macaques by Ebola Virus Glycoprotein Synthetic DNA Vaccines.
    Patel A; Reuschel EL; Kraynyak KA; Racine T; Park DH; Scott VL; Audet J; Amante D; Wise MC; Keaton AA; Wong G; Villarreal DO; Walters J; Muthumani K; Shedlock DJ; de La Vega MA; Plyler R; Boyer J; Broderick KE; Yan J; Khan AS; Jones S; Bello A; Soule G; Tran KN; He S; Tierney K; Qiu X; Kobinger GP; Sardesai NY; Weiner DB
    J Infect Dis; 2019 Jan; 219(4):544-555. PubMed ID: 30304515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates.
    Marzi A; Halfmann P; Hill-Batorski L; Feldmann F; Shupert WL; Neumann G; Feldmann H; Kawaoka Y
    Science; 2015 Apr; 348(6233):439-42. PubMed ID: 25814063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus.
    Mohan GS; Li W; Ye L; Compans RW; Yang C
    PLoS Pathog; 2012; 8(12):e1003065. PubMed ID: 23271969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses.
    Plummer JR; McGettigan JP
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007800. PubMed ID: 31725816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals.
    Yang L; Sanchez A; Ward JM; Murphy BR; Collins PL; Bukreyev A
    Virology; 2008 Aug; 377(2):255-64. PubMed ID: 18570964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.
    Ledgerwood JE; Costner P; Desai N; Holman L; Enama ME; Yamshchikov G; Mulangu S; Hu Z; Andrews CA; Sheets RA; Koup RA; Roederer M; Bailer R; Mascola JR; Pau MG; Sullivan NJ; Goudsmit J; Nabel GJ; Graham BS;
    Vaccine; 2010 Dec; 29(2):304-13. PubMed ID: 21034824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rational design of self-amplifying virus-like vesicles with Ebola virus glycoprotein as vaccines.
    Zhang HQ; Zhang YN; Deng CL; Zhu QX; Zhang ZR; Li XD; Yuan ZM; Zhang B
    Mol Ther; 2024 Oct; 32(10):3695-3711. PubMed ID: 39217415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Designing Efficacious Vesicular Stomatitis Virus-Vectored Vaccines Against Ebola Virus.
    Wong G; Qiu X
    Methods Mol Biol; 2016; 1403():245-57. PubMed ID: 27076134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins.
    Wu S; Yu T; Song X; Yi S; Hou L; Chen W
    Virol J; 2012 Jun; 9():111. PubMed ID: 22695180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice.
    Park JE; Shin HJ
    Vet Q; 2021 Dec; 41(1):202-209. PubMed ID: 33985418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutralizing Antibody Titer Test of Ebola Recombinant Protein Vaccine and Gene Vector Vaccine pVR-GP-FC.
    Yang R; Zhu Y; Ma J; Hao YZ; Wang X; Hou ML; Liu LP; Fan LY; Cao YX; Zhang XG; Li XJ
    Biomed Environ Sci; 2018 Oct; 31(10):721-728. PubMed ID: 30423273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
    Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP
    Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques.
    Feng Y; Li C; Hu P; Wang Q; Zheng X; Zhao Y; Shi Y; Yang S; Yi C; Feng Y; Wu C; Qu L; Xu W; Li Y; Sun C; Gao FG; Xia X; Feng L; Chen L
    Emerg Microbes Infect; 2018 Jun; 7(1):101. PubMed ID: 29872043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.